Literature DB >> 2380354

Serological response to Chlamydia pneumoniae infection.

L A Campbell1, C C Kuo, S P Wang, J T Grayston.   

Abstract

The human serological response was analyzed by using sera from patients who were serologically positive but isolation negative for Chlamydia pneumoniae and from patients with proven C. pneumoniae infection based on serology and isolation. To assess whether seroreactivity to C. pneumoniae proteins had potential diagnostic value, the cross-reactivities of these sera to other Chlamydia species and of sera from patients infected with C. trachomatis and C. psittaci to C. pneumoniae proteins were determined. In all serum samples from patients with proven C. pneumoniae infections, reactivities were seen with 98-, 68-, 60-, 39.5-, and 30-kilodalton proteins. Similar patterns were seen in sera from patients who were serologically positive and isolation negative. The onset of seropositivity for C. pneumoniae was accompanied by reactivities against presumably shared chlamydial antigens and a C. pneumoniae-specific 98-kilodalton protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380354      PMCID: PMC267915          DOI: 10.1128/jcm.28.6.1261-1264.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  OCCURENCE OF GLYCOGEN IN INCLUSIONS OF THE PSITTACOSIS-LYMPHOGRANULOMA VENEREUM-TRACHOMA AGENTS.

Authors:  F B GORDON; A L QUAN
Journal:  J Infect Dis       Date:  1965-04       Impact factor: 5.226

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Purification on renografin density gradients of Chlamydia trachomatis grown in the yolk sac of eggs.

Authors:  L Howard; N S Orenstein; N W King
Journal:  Appl Microbiol       Date:  1974-01

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Expression in E. coli of Chlamydia trachomatis antigen recognized during human infection.

Authors:  W M Wenman; M A Lovett
Journal:  Nature       Date:  1982-03-04       Impact factor: 49.962

6.  Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR).

Authors:  S Ladany; C M Black; C E Farshy; J M Ossewaarde; R C Barnes
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  Structural and antigenic analysis of Chlamydia pneumoniae.

Authors:  L A Campbell; C C Kuo; J T Grayston
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

8.  Analysis of the human serological response to proteins of Chlamydia trachomatis.

Authors:  W J Newhall; B Batteiger; R B Jones
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.

Authors:  P Saikku; S P Wang; M Kleemola; E Brander; E Rusanen; J T Grayston
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

View more
  31 in total

1.  Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae.

Authors:  Olga Tapia; Anatoly Slepenkin; Evgueni Sevrioukov; Kathi Hamor; Luis M de la Maza; Ellena M Peterson
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Antigenic and molecular analyses of different Chlamydia pneumoniae strains.

Authors:  C A Jantos; S Heck; R Roggendorf; M Sen-Gupta; J H Hegemann
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 3.  Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses.

Authors:  P Andersen
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

4.  Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae.

Authors:  K Knudsen; A S Madsen; P Mygind; G Christiansen; S Birkelund
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

5.  Defining species-specific immunodominant B cell epitopes for molecular serology of Chlamydia species.

Authors:  K Shamsur Rahman; Erfan U Chowdhury; Anil Poudel; Anke Ruettger; Konrad Sachse; Bernhard Kaltenboeck
Journal:  Clin Vaccine Immunol       Date:  2015-03-11

6.  Identification of Chlamydia pneumoniae-specific protein antigens in immunoblots.

Authors:  H M Freidank; A S Herr; E Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

7.  Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model.

Authors:  Ulla Airaksinen; Tuula Penttilä; Eva Wahlström; Jenni M Vuola; Mirja Puolakkainen; Matti Sarvas
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

8.  Sequence analysis of the major outer membrane protein gene of Chlamydia pneumoniae.

Authors:  M Perez Melgosa; C C Kuo; L A Campbell
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

9.  Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans.

Authors:  Y Iijima; N Miyashita; T Kishimoto; Y Kanamoto; R Soejima; A Matsumoto
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

10.  Antigenic variation among strains of Chlamydia pneumoniae.

Authors:  C M Black; J E Johnson; C E Farshy; T M Brown; B P Berdal
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.